Cross Matching Purpose, Types, Procedure, and Results

Blood Crossmatching (Compatibility Testing) is the ultimate and most critical pre-transfusion safety measure performed in clinical blood banks worldwide. Its primary objective is to guarantee that the donor’s blood is highly compatible with the recipient, thereby preventing potentially fatal acute or delayed hemolytic transfusion reactions. With the evolution of medical science, this procedure spans comprehensive serological setups—covering Major, Minor, Reverse, and Auto testing.

Blood Compatibility Tool: Universal Matrix

Before any physical, gel, or electronic crossmatch is initiated, establishing ABO and RhD compatibility is the absolute prerequisite. Use this master matrix to determine safe donation and reception pathways.

Blood Type	Can Donate Red Blood Cells To	Can Receive Red Blood Cells From
O Negative (O-)	All Blood Types (The Universal Donor)	O- Only
O Positive (O+)	O+, A+, B+, AB+	O+, O-
A Negative (A-)	A-, A+, AB-, AB+	A-, O-
A Positive (A+)	A+, AB+	A+, A-, O+, O-
B Negative (B-)	B-, B+, AB-, AB+	B-, O-
B Positive (B+)	B+, AB+	B+, B-, O+, O-
AB Negative (AB-)	AB-, AB+	AB-, A-, B-, O-
AB Positive (AB+)	AB+ Only	All Blood Types (The Universal Recipient)

Donors and Recipients: Strict Preparatory Protocols

Clerical errors are the leading cause of fatal transfusion reactions. Therefore, strict AABB (Association for the Advancement of Blood & Biotherapies) protocols must be followed flawlessly.

The Recipient (Patient)

Zero-Tolerance ID Check: Two independent identifiers (e.g., Full Name and Medical Record Number) must be verified at the bedside before drawing blood.
Sample Collection: Drawn into EDTA (Pink/Purple top) or Plain (Red top) tubes. Hemolyzed samples are strictly rejected as they mask in-vitro hemolysis.
Labeling: Tubes must be labeled, signed, and dated at the patient’s bedside, never at the nurse’s station.
Historical Review: Laboratory Information Systems (LIS) must be checked for historical ABO/Rh records and previous clinically significant antibodies.

The Donor Unit

Rigorous Screening: Health history questionnaire, travel history, and hemoglobin/vital checks are performed before donation.
Infectious Disease Testing: Units are tested for HIV, Hep B/C, Syphilis, HTLV, and West Nile Virus using highly sensitive NAT (Nucleic Acid Testing).
Segment Preparation: Sterile tubing segments (“pigtails”) attached to the donor blood bag are separated and used for the crossmatch, preserving the sterility of the main packed red cell unit.

The 4 Pillars of Cross Matching

A complete compatibility profile requires testing multiple serological variables to ensure patient safety. Here is a breakdown of the four core combinations utilized in immunohematology.

1. Major Cross Match

Formula: Recipient’s Serum/Plasma + Donor’s Red Blood Cells.

Principle: Detects clinically significant unexpected antibodies (like anti-Kell, anti-Duffy) in the patient’s plasma that could aggressively attack and destroy the transfused donor cells.

Why & When: The absolute mandatory test prior to the transfusion of any cellular blood product (Packed RBCs or Whole Blood).

1. Minor Cross Match

Formula: Donor’s Serum/Plasma + Recipient’s Red Blood Cells.

Principle: Detects antibodies in the donor’s plasma directed against the patient’s RBC antigens.

Why & When: Historically used for Whole Blood transfusions. Today, it is largely obsolete because modern blood banking removes donor plasma to create Packed RBCs, but it remains a foundational concept in blood banking education.

3. Reverse Cross Match (Reverse Grouping)

Formula: Recipient’s Serum/Plasma + Reagent A1 and B Cells.

Principle: Detects naturally occurring expected ABO antibodies (Isoagglutinins) to validate the forward antigen typing.

Why & When: Always performed concurrently with forward ABO typing. Discrepancies between forward and reverse typing must be resolved before any blood is issued.

4. Auto Cross Match (Auto-Control)

Formula: Recipient’s Serum/Plasma + Recipient’s Own RBCs.

Principle: Determines if the patient possesses autoantibodies or abnormal plasma proteins causing spontaneous agglutination.

Why & When: Run alongside the major crossmatch and antibody screens. A positive auto-control indicates Autoimmune Hemolytic Anemia (AIHA), rouleaux, or medication-induced antibodies.

Comprehensive Step-by-Step Procedures: Traditional Tube Method

The manual tube method utilizing the Indirect Antiglobulin Test (IAT) principle remains the universal gold standard for resolving complex antibody problems. Below are the precise, comprehensive protocols for all four methodologies.

Cross Match	Detects Antibody of Type :
Saline Cross Match	IgM
Albumin Cross Match	IgG
Anti-Human Globulin (AHG) Cross Match	IgG

Major Cross Match Tube Protocol

Testing Recipient Plasma against Donor Cells.

Sample Preparation: Extract Donor RBCs from the unit segment. Wash them once with normal saline and prepare a 3-5% cell suspension. Centrifuge the recipient’s sample to isolate clear plasma/serum.
Phase 1: Immediate Spin (IS) Phase: Label a glass test tube. Add 2 drops of Recipient Serum + 1 drop of Donor RBC suspension. Mix gently and centrifuge at 3400 RPM for 15 seconds. Read immediately against a lighted background. (Detects cold-reacting IgM antibodies like ABO incompatibilities).
Phase 2: Enhancement & Incubation (37°C Phase): Add 2 drops of an enhancement medium (LISS – Low Ionic Strength Solution, or PEG – Polyethylene Glycol). Incubate in a dry block or water bath at exactly 37°C for 15 to 30 minutes. Centrifuge and read again. (Allows warm-reacting IgG antibodies to sensitize the red cells).
Phase 3: The Washing Phase: Fill the tube forcefully with normal saline, centrifuge for 1 minute, and decant completely. Repeat this 3 to 4 times. This critical step removes all unbound globulins that could neutralize the AHG reagent. After the final wash, blot the tube dry.
Phase 4: Anti-Human Globulin (AHG/Coombs) Phase: Add 2 drops of polyspecific AHG reagent to the dry cell button. Mix gently, centrifuge for 15 seconds, and read macroscopically and microscopically. (Detects clinically significant IgG antibodies like Rh, Kell, Kidd, and Duffy).
Phase 5: Validation (Check Cells): To any tube that tests negative at the AHG phase, add 1 drop of Coombs Control Cells (Check Cells). Centrifuge and read. Agglutination (usually 2+ or 3+) must occur to prove the washing was adequate and the AHG reagent was active. If negative, the entire test is invalid.

Minor Cross Match Tube Protocol

Testing Donor Plasma against Recipient Cells.

Sample Preparation: Prepare a 3-5% RBC suspension of the Recipient’s blood. Extract clear serum/plasma from the Donor’s segment.
Immediate Spin (IS) Phase: In a clearly labeled tube, add 2 drops of Donor Serum + 1 drop of Recipient RBC suspension. Centrifuge at 3400 RPM for 15 seconds and check for immediate macroscopic agglutination or hemolysis.
Incubation (37°C Phase): Add 2 drops of enhancement media (LISS/PEG). Incubate the mixture at 37°C for 15 to 30 minutes. This facilitates the binding of potential donor IgG antibodies to recipient red cell antigens.
Washing & AHG Phase: Wash the cells strictly 3 to 4 times with normal saline to remove unbound donor proteins. Decant completely, add 2 drops of AHG reagent, centrifuge, and read.
Validation: Confirm any negative AHG results by adding 1 drop of IgG-coated Check Cells to validate the procedure.

Reverse Grouping Tube Protocol

Validating the Forward ABO type by identifying natural isoagglutinins.

Setup & Labeling: Label two clean glass test tubes: one as “A1” and the other as “B”.
Serum Addition: Carefully pipette 2 drops of the Recipient’s Serum/Plasma into both the “A1” and “B” tubes.
Reagent Cells Addition: Add 1 drop of commercially prepared A1 Reagent Red Blood Cells to the “A1” tube. Add 1 drop of commercially prepared B Reagent Red Blood Cells to the “B” tube.
Execution & Reading: Mix gently and centrifuge both tubes for 15 to 20 seconds at 3400 RPM. Gently resuspend the cell buttons and observe for agglutination. (Expected result: A Type A patient will agglutinate in the B tube; a Type O patient will agglutinate in both).

Auto-Control Tube Protocol

Testing Recipient Plasma against Recipient Cells to rule out auto-immunity.

Setup: Prepare a 3-5% suspension of the Recipient’s own red blood cells. Ensure you have clear, unhemolyzed recipient serum/plasma.
Reaction Mixture: In a tube labeled “Auto”, mix 2 drops of Recipient Serum + 1 drop of Recipient RBC suspension.
Parallel Execution: Process this tube identically and in parallel to the Major Crossmatch. Read it at Immediate Spin (IS), incubate at 37°C with enhancement media, perform the 3-4 wash cycles, and finalize with the AHG phase.
Interpretation: This serves as the ultimate baseline control. A positive Auto-Control invalidates standard crossmatching, suggesting the patient has circulating autoantibodies, rouleaux-causing plasma expanders, or cold agglutinins.

Quick Exam Summary

Crossmatch Type	Key Concept
Major	Recipient serum + Donor RBCs
Monir	Donor serum + Recipient RBCs
Reverse	Recipient RBCs + Known serum
Auto	Patient serum + Patient RBCs

Modern Advanced Cross Matching Methodologies

Modern laboratories have evolved past manual test tubes to increase throughput, remove human subjectivity, and improve sensitivity.

Advanced Column Agglutination Technology (Gel Method)

The Gel test uses specially designed plastic cards containing microtubes filled with a dextran acrylamide gel matrix impregnated with AHG reagent. It completely eliminates the manual washing phase and provides a stable, photographable result.

Suspension Preparation: Prepare a precise 0.8% or 1% suspension of Donor RBCs using a specific Low Ionic Strength Diluent (LISS).
Card Labeling: Appropriately label the patient ID and donor unit number on an anti-IgG Gel Card. Carefully peel back the foil seal.
Micro-Pipetting: Using a calibrated pipette, dispense 50 µL of the 0.8% Donor RBC suspension into the microtube. Next, precisely dispense 25 µL of the Recipient’s Plasma/Serum into the same microtube.
Incubation: Place the Gel Card into a specialized gel incubator at 37°C for exactly 15 minutes.
Centrifugation: Transfer the card to a gel card centrifuge (spins at specific, standardized G-forces) for 10 minutes.
Interpretation:
- Positive (Incompatible): Agglutinated red cells are trapped at the top or suspended within the gel matrix (graded 1+ to 4+).
- Negative (Compatible): Unagglutinated red cells slip entirely through the gel and form a compact red pellet at the very bottom of the microtube.

Digital The Electronic Crossmatch (EXM / Computer Crossmatch)

The EXM utilizes robust Laboratory Information System (LIS) logic to determine compatibility instantly, without any physical serological mixing of donor and recipient blood. This is the fastest method available, enabling units to be released in seconds in emergency settings.

Strict Prerequisites for EXM: To legally and safely perform an electronic crossmatch, the patient must have: 1) No history of clinically significant unexpected antibodies. 2) A current antibody screen that is completely negative. 3) At least TWO independent, concordant ABO/Rh determinations on file.

Data Verification: The LIS continuously monitors the patient’s record to ensure all pre-requisites are met.
Unit Selection: The technologist selects an ABO/Rh compatible donor blood unit from inventory based on the logic rules.
Barcode Scanning: Using an ISBT 128 barcode scanner, the technologist scans the patient’s accession number, the Donor Unit Number, and the Donor Blood Type.
Algorithmic Check: The computer system verifies the logic. If compatible, it immediately approves the unit. If incompatible or if the patient has a historical antibody, the system triggers a hard-stop alarm and forces a serological (Tube/Gel) crossmatch.
Issuance: A compatibility tag is automatically printed and affixed to the blood bag.

Result Interpretation & Clinical Action

Accurate interpretation dictates clinical action. Misreading a reaction can result in a fatal Hemolytic Transfusion Reaction (HTR).

Observation (Tube/Gel)	Clinical Interpretation	Required Action
No Agglutination & No Hemolysis (Pellet at bottom of Gel / Smooth resuspension in Tube)	Compatible No detectable antibodies reacting against donor antigens.	Safe to Transfuse. Print compatibility tags and release the unit to the clinical ward.
Agglutination or Hemolysis at ANY phase (IS, 37°C, or AHG)	Incompatible Recipient possesses antibodies actively destroying or clumping donor RBCs.	DO NOT TRANSFUSE. Quarantine the donor unit. Initiate a full Antibody Identification Panel to determine the exact antibody specificity, then perform antigen-negative crossmatching.
Positive Auto-Control (Major crossmatch may be positive or negative)	Autoimmune/Interference Patient serum reacting with their own cells.	Perform a Direct Antiglobulin Test (DAT). Investigate for Autoimmune Hemolytic Anemia (AIHA), recent transfusions, or drug-induced antibodies.